Global Heart Lung Machine Market Growth 2023-2029

Global Heart Lung Machine Market Growth 2023-2029

Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
LPI (LP Information)' newest research report, the “Heart Lung Machine Industry Forecast” looks at past sales and reviews total world Heart Lung Machine sales in 2022, providing a comprehensive analysis by region and market sector of projected Heart Lung Machine sales for 2023 through 2029. With Heart Lung Machine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heart Lung Machine industry.
This Insight Report provides a comprehensive analysis of the global Heart Lung Machine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Heart Lung Machine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Heart Lung Machine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heart Lung Machine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heart Lung Machine.
The global Heart Lung Machine market size is projected to grow from US$ 283.4 million in 2022 to US$ 358.7 million in 2029; it is expected to grow at a CAGR of 358.7 from 2023 to 2029.
North America is the largest sales place, with a sales market share nearly 36%. Following North America, Europe is the second largest sales place with the sales market share of 33%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59% of revenue share. MAQUET followed as second produced about 18%.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart Lung Machine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Single Roller Pump Heart Lung Machine
Double Roller Pump Heart Lung Machine
Segmentation by application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Heart Lung Machine market?
What factors are driving Heart Lung Machine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Heart Lung Machine market opportunities vary by end market size?
How does Heart Lung Machine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.